Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by spesestsemperon Aug 21, 2024 11:32am
174 Views
Post# 36189881

My problem

My problemThis is how I see it . All in my opinion of course . They need to do a deal now . I would prefer a straight sale of the company . I still maintain $500 million would be good . I get that is way below somes expectations on this board but I just don't see them getting anything more than 5x the current value roughly . If they choose to go alone ,, they better come up with a huge development deal with a big player . My opinion with the latest chat they had , is there was no sense of urgency at all . Nobody here is going to wait around for years on end . I knew going in I wasn't fond of mangement but I hoped there was still some money to be made here . Still think I'm going to make out alright but the share price shows that they can not generate any interest . That should be a flashing neon light to the company . Maybe some management should step up and start buying some shares , show their confidence in the company . Just some idle ramblings on this morning .
<< Previous
Bullboard Posts
Next >>